scPharmaceuticals said in late April that it named pharma-veteran John Tucker as president & CEO, effective immediately. Tucker was also elected to the company’s board of directors. Tucker formerly served as CEO of Alcresta, where he led regulatory and financing strategies for the company’s 1st product approval and launch. He also worked as Incline Therapeutics’ […]
Frequency Therapeutics
Frequency raises $32m in Series A for hearing loss therapy
Frequency Therapeutics said today that it closed a $32 million Series A round, led by CoBro Ventures. Morningside Ventures, Emigrant Capital Corp., Korean Investment Partnership, Alexandria Real Estate Equities and other groups also invested in the round. The company has developed a proprietary combination of small molecule drugs that they plan to inject in the ear, […]
The stem cell therapy that could reverse hearing loss
Frequency Therapeutics is betting that it can change the lives of millions of Americans with hearing loss, by triggering the body’s natural ability to heal itself. Researchers have used cells in regenerative medicine for decades – in 1931, the father of cell therapy, Paul Niehans, treated a patient with material from calf embryos. Although today’s […]
Frequency Therapeutics names board of directors
Frequency Therapeutics named its board of directors last week, the company’s 1st public move since it was founded in 2015. Marc Cohen of COBRO Ventures was named chairman. Founder and former CEO of Sepracor, Inc., joined the board as well as Marc Kozin, senior advisor and former president of L.E.K. Consulting. Robert Langer, who co-founded […]
